论文部分内容阅读
脾切除术是为了诊断(如:何杰金氏病),或为了治疗(如:特发性血小板减少症),另外为促进化疗或减轻脾亢以及为缓解由于脾脏的大小和重量给患者造成的诸多不便。有人报告切除巨脾(脾重量在1500g 以上)的罹病率和死亡数都比切除小脾的高,本文重点讨论了这个问题。为治疗白血病,1972年至1982年243例患者作了脾切除术。其中有巨脾49例(男34例,女15例,年龄20～73岁,平均年龄50岁)占20%。手术前194例小脾患者中52例(占27%)接受了皮质类甾醇和/或
Splenectomy is for diagnosis (eg, Hodgkin’s disease), or for treatment (eg idiopathic thrombocytopenia), in addition to promoting chemotherapy or reducing hypersplenism and for relieving the patient of the size and weight of the spleen Many inconveniences. Some people report removal of splenomegaly (spleen weight in more than 1500g) morbidity and mortality than the excision of the spleen is high, this article focuses on this issue. To treat leukemia, 243 patients underwent splenectomy between 1972 and 1982. There are 49 cases of giant spleen (34 males and 15 females, aged 20 to 73 years, mean age 50 years) accounted for 20%. Of the 194 patients with spleen before surgery, 52 (27%) received corticosteroids and / or